Management of Infections Due to Antibiotic-Resistant Streptococcus pneumoniae

SUMMARY Antibiotic-resistant strains of Streptococcus pneumoniae are becoming more prevalent throughout the world; this has resulted in modifications of treatment approaches. Management of bacterial meningitis has the greatest consensus. Strategies for treating other systemic infections such as pneumonia, bacteremia, and musculoskeletal infections are evolving, in part related to the availability of new antibiotics which are active in vitro against isolates resistant to penicillin and the extended-spectrum cephalosporins. However, there are currently very limited data related to the clinical efficacy of these new agents. The studies upon which current recommendations are based are reviewed. Otitis media represents the single most common infection due to S. pneumoniae. Recommendations for treatment of acute otitis media due to drug-resistant strains and the rationale for these recommendations are discussed.

[1]  G. Mccracken,et al.  Middle ear fluid concentrations of amoxicillin after large dosages in children with acute otitis media. , 1998, The Pediatric infectious disease journal.

[2]  S. Naraqi,et al.  Relapsing pneumococcal meningitis: isolation of an organism with decreased susceptibility to penicillin G. , 1974, The Journal of pediatrics.

[3]  J. B. D. Bernaldo de Quirós,et al.  Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  M. Marks,et al.  Ceftriaxone therapy in pediatric patients. , 1983, American journal of diseases of children.

[5]  S. Kaplan,et al.  Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. , 1994, The Pediatric infectious disease journal.

[6]  G. Mccracken,et al.  Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis , 1995, Antimicrobial agents and chemotherapy.

[7]  D. Greenblatt,et al.  Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function. , 1981, Reviews of infectious diseases.

[8]  J. Nelson,et al.  A pharmacologic evaluation of penicillin in children with purulent meningitis. , 1977, The New England journal of medicine.

[9]  S. Kaplan,et al.  Three-Year Multicenter Surveillance of Pneumococcal Meningitis in Children: Clinical Characteristics, and Outcome Related to Penicillin Susceptibility and Dexamethasone Use , 1998, Pediatrics.

[10]  R. Michaels,et al.  Meningitis from a pneumococcus moderately resistant to penicillin. , 1979, JAMA.

[11]  K. Klugman,et al.  Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis , 1992, The Lancet.

[12]  M. Cetron,et al.  The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. , 1996, The Journal of infectious diseases.

[13]  T. Gudnason,et al.  Penetration of ceftriaxone into the middle ear fluid of children. , 1998, The Pediatric infectious disease journal.

[14]  K. Tateda,et al.  Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model , 1996, Antimicrobial agents and chemotherapy.

[15]  S. Kaplan,et al.  Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. , 1998, Pediatrics.

[16]  G. Weinberg,et al.  Meningitis with beta-lactam-resistant Streptococcus pneumoniae: the need for early repeat lumbar puncture. , 1993, The Pediatric infectious disease journal.

[17]  F. Altice,et al.  Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  G. Mccracken,et al.  Relatively penicillin‐resistant pneumococcal infections in pediatric patients , 1984, Pediatric infectious disease.

[19]  I. Friedland.  Comparison of the response to antimicrobial therapy of penicillin‐resistant and penicillin‐susceptible pneumococcal disease , 1995, The Pediatric infectious disease journal.

[20]  R. Jones,et al.  Antimicrobial activity and spectrum of sparfloxacin tested against erythromycin-resistant Streptococcus pneumoniae isolates. , 1996, Diagnostic microbiology and infectious disease.

[21]  C. Cabellos,et al.  Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis , 1995, Antimicrobial agents and chemotherapy.

[22]  S. Miyazaki,et al.  In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives , 1994, Antimicrobial Agents and Chemotherapy.

[23]  E. Bingen,et al.  Comparative In Vitro Killing Activities of Meropenem, Imipenem, Ceftriaxone, and Ceftriaxone plus Vancomycin at Clinically Achievable Cerebrospinal Fluid Concentrations against Penicillin-Resistant Streptococcus pneumoniaeIsolates from Children with Meningitis , 1998, Antimicrobial Agents and Chemotherapy.

[24]  C. Cabellos,et al.  Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. , 1995, The New England journal of medicine.

[25]  W. J. Novick.  Levels of cefotaxime in body fluids and tissues: a review. , 1982, Reviews of Infectious Diseases.

[26]  K. Klugman.  Pneumococcal resistance to antibiotics , 1990, Clinical Microbiology Reviews.

[27]  J. A. Donkersloot,et al.  Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae. , 1997, The Journal of antimicrobial chemotherapy.

[28]  B. Schwartz,et al.  Therapy for children with invasive pneumococcal infections , 1997 .

[29]  A. Medeiros,et al.  Meningitis due to ceftriaxone-resistant Streptococcus pneumoniae. , 1995, The New England journal of medicine.

[30]  G. Doern,et al.  In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. , 1996, Diagnostic microbiology and infectious disease.

[31]  K. Klugman,et al.  Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime , 1997, Antimicrobial agents and chemotherapy.

[32]  C. Custalow.  Penicillin-resistant streptococcus pneumoniae in acute otitis media: Risk factors, susceptibility patterns and antimicrobial management , 1996 .

[33]  G. Mccracken,et al.  Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. , 1993, The Pediatric infectious disease journal.

[34]  M. Jacobs,et al.  MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci , 1996, Antimicrobial agents and chemotherapy.

[35]  G. Chéron,et al.  Concentrations of ceftriaxone in cerebrospinal fluid of children with meningitis receiving dexamethasone therapy , 1994, Antimicrobial Agents and Chemotherapy.

[36]  S. Kaplan,et al.  Systemic infections due to Streptococcus pneumoniae relatively resistant to penicillin in a children's hospital: clinical management and outcome. , 1992, Pediatrics.

[37]  M. Guibert,et al.  Failure of cefotaxime treatment in two children with meningitis caused by highly penicillin‐resistant Streptococcus pneumoniae , 1995, Acta paediatrica.

[38]  S. Block,et al.  Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae , 1997, Antimicrobial agents and chemotherapy.

[39]  J. C. West,et al.  Review of pneumococcal endocarditis in adults in the penicillin era. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  R. Bradsher.  Ceftriaxone (Ro 13-9904) therapy of serious infection , 1982, Antimicrobial Agents and Chemotherapy.

[41]  M. Pichichero,et al.  Persistent acute otitis media: I. Causative pathogens , 1995, The Pediatric infectious disease journal.

[42]  W. Bonadio.  Dexamethasone therapy for bacterial meningitis. , 1996, The New England journal of medicine.

[43]  M. Jacobs,et al.  MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci , 1996, Antimicrobial agents and chemotherapy.

[44]  W. Scheld,et al.  The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  W. Scheld,et al.  Treatment of bacterial meningitis. , 1997, The New England journal of medicine.

[46]  J. Plouffe.  Levofloxacin in vitro activity against bacteremic isolates of Streptococcus pneumoniae. Franklin County Pneumonia Study Group. , 1996, Diagnostic microbiology and infectious disease.

[47]  F. Tenover,et al.  Nosocomial epiglottitis associated with penicillin- and cephalosporin-resistant Streptococcus pneumoniae bacteremia , 1994, Journal of clinical microbiology.

[48]  C. Feldman,et al.  Community-acquired pneumonia due to penicillin-resistant pneumococci. , 1985, The New England journal of medicine.

[49]  B. Williams,et al.  The penetration of ceftriaxone into synovial fluid of the inflamed joint. , 1985, The Journal of antimicrobial chemotherapy.

[50]  S. Kaplan,et al.  Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins , 1994, Antimicrobial Agents and Chemotherapy.

[51]  G. Mccracken,et al.  Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children , 1995, Antimicrobial agents and chemotherapy.

[52]  R. L. Sauer,et al.  Penicillin-resistant pneumococcal meningitis in an immunocompromised infant. , 1977, The Journal of pediatrics.

[53]  Charles K. Cooper,et al.  Failure of cefotaxime treatment in an adult with Streptococcus pneumoniae meningitis. , 1997, The American journal of medicine.

[54]  S. Bobin,et al.  Twice daily cefpodoxime proxetil compared with thrice daily amoxicillin/clavulanic acid for treatment of acute otitis media in children. , 1994, Scandinavian journal of infectious diseases.

[55]  P. Berche,et al.  In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media , 1995, Antimicrobial agents and chemotherapy.

[56]  D. Pérez-Tamarit,et al.  Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus. , 1989, The Pediatric Infectious Disease Journal.

[57]  S. Kaplan,et al.  In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae , 1996, Antimicrobial agents and chemotherapy.

[58]  W. Craig,et al.  Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. , 1996, The Pediatric infectious disease journal.

[59]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .

[60]  R. Jones,et al.  Comparative in-vitro activity of quinupristin/dalfopristin (RP 59500) tested against penicillin-and macrolide-resistant pneumococci by the Etest. , 1996, The Journal of antimicrobial chemotherapy.

[61]  G. Mccracken,et al.  Consensus report: antimicrobial therapy for bacterial meningitis in infants and children , 1987, The Pediatric infectious disease journal.

[62]  J. A. Donkersloot,et al.  Penicillin-resistant pneumococci from pediatric patients in the Washington, DC, area. , 1995, Archives of pediatrics & adolescent medicine.

[63]  S. Day,et al.  Penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell disease. , 1995, The Journal of pediatrics.

[64]  M. Harper,et al.  Clinical implications of penicillin and ceftriaxone resistance among children with pneumococcal bacteremia. , 1999, The Pediatric infectious disease journal.

[65]  V. Dhawan,et al.  Clindamycin: a review of fifteen years of experience. , 1982, Reviews of infectious diseases.

[66]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[67]  W. Dankner.  The Continued Emergence of Drug-Resistant Streptococcus pneumoniae in the United States: An Update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System , 1997 .

[68]  S. Kaplan,et al.  Three-year multicenter surveillance of systemic pneumococcal infections in children. , 1998, Pediatrics.

[69]  W. Doyle,et al.  Efficacy of clarithromycin treatment of acute otitis media caused by infection with penicillin-susceptible, -intermediate, and -resistant Streptococcus pneumoniae in the chinchilla , 1996, Antimicrobial agents and chemotherapy.

[70]  Claude Carbón,et al.  Efficacy of single-dose ceftriaxone in experimental otitis media induced by penicillin- and cephalosporin-resistant Streptococcus pneumoniae , 1996, Antimicrobial agents and chemotherapy.

[71]  F. Gudiol,et al.  Treatment of penicillin-resistant pneumococcal bacteremia in neutropenic patients with cancer. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[72]  Y. Sultan,et al.  Dexamethasone treatment for bacterial meningitis in children and adults , 1989, The Pediatric infectious disease journal.

[73]  E. Bingen,et al.  Comparative In Vitro Killing Activities of Meropenem, Imipenem, Ceftriaxone, and Ceftriaxone plus Vancomycin at Clinically Achievable Cerebrospinal Fluid Concentrations against Penicillin-Resistant Streptococcus pneumoniaeIsolates from Children with Meningitis , 1998, Antimicrobial Agents and Chemotherapy.

[74]  K. Olsen,et al.  Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis , 1993, Antimicrobial Agents and Chemotherapy.

[75]  W. Hardie,et al.  Complicated Parapneumonic Effusions in Children Caused by Penicillin-Nonsusceptible Streptococcus pneumoniae , 1998, Pediatrics.

[76]  C. Cabellos,et al.  High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins , 1996, Antimicrobial agents and chemotherapy.

[77]  R. Breiman,et al.  Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group. , 1996, JAMA.

[78]  E. Bouza,et al.  Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[79]  W. Brück,et al.  Rifabutin for experimental pneumococcal meningitis. , 1997, Chemotherapy.

[80]  K. Edwards,et al.  Concerns of secondary fever in Streptococcus pneumoniae meningitis in an era of increasing antibiotic resistance. , 1996, Archives of pediatrics & adolescent medicine.

[81]  K. Olsen,et al.  Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis , 1994, Antimicrobial Agents and Chemotherapy.

[82]  M. Laguarda,et al.  Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats , 1997, Antimicrobial agents and chemotherapy.

[83]  B. Oppenheim,et al.  Antibiotic‐resistant pneumococcal disease in children at Baragwanath Hospital, Johannesburg , 1986, Pediatric infectious disease.

[84]  C. Regamey.  Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime. , 1985, Chemotherapy.

[85]  M. Täuber,et al.  Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae , 1997, Antimicrobial agents and chemotherapy.

[86]  T. File,et al.  A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia , 1997, Antimicrobial agents and chemotherapy.

[87]  M. Jacobs,et al.  Activity of CP99,219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci. , 1995, The Journal of antimicrobial chemotherapy.

[88]  A. Hoberman,et al.  Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility. , 1996, The Pediatric infectious disease journal.

[89]  M. Jacobs,et al.  Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococci , 1996, Antimicrobial agents and chemotherapy.

[90]  M. Muffat‐Joly,et al.  Effect of increased dosages of amoxicillin in treatment of experimental middle ear otitis due to penicillin-resistant Streptococcus pneumoniae , 1993, Antimicrobial Agents and Chemotherapy.

[91]  C. Berkey,et al.  Dexamethasone as Adjunctive Therapy in Bacterial Meningitis. A Meta-Analysis of Randomized Clinical Trials Since 1988 , 1997 .

[92]  J. Blumer,et al.  Cefprozil treatment of persistent and recurrent acute otitis media. , 1997, The Pediatric infectious disease journal.

[93]  J. Pocidalo,et al.  In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model , 1994, Antimicrobial Agents and Chemotherapy.

[94]  Claude Carbón,et al.  Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae , 1996, Antimicrobial agents and chemotherapy.

[95]  P. Tebas,et al.  Resistance to penicillin and non-beta-lactam antibiotics of Streptococcus pneumoniae at a children's hospital. , 1994, The Pediatric infectious disease journal.

[96]  T. Chonmaitree,et al.  Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media. , 1998, The Pediatric infectious disease journal.

[97]  M. Grossman.  Steroid therapy for bacterial meningitis. , 1990, The Western journal of medicine.

[98]  C. Marr,et al.  Concentration of cefuroxime in middle ear effusion of children with acute otitis media. , 1997, The Pediatric infectious disease journal.

[99]  R. Dagan,et al.  Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges. , 1994, The Journal of antimicrobial chemotherapy.

[100]  F. Soriano,et al.  Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime, and meropenem , 1996, Antimicrobial agents and chemotherapy.

[101]  J. Ariza,et al.  Evaluation of vancomycin for therapy of adult pneumococcal meningitis , 1991, Antimicrobial Agents and Chemotherapy.

[102]  S. Rothrock,et al.  Single-dose intramuscular ceftriaxone for acute otitis media in children. , 1993, Pediatrics.

[103]  K. Klugman,et al.  Penetration of cefpodoxime into middle ear fluid in pediatric patients with acute otitis media. , 1997, The Pediatric infectious disease journal.

[104]  J. Hedrick,et al.  Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. , 1995 .

[105]  J. Bartlett,et al.  GUIDELINES FROM THE INFECTIOUS DISEASES SOCIETY OF AMERICA Community-Acquired Pneumonia in Adults: Guidelines for Management , 1998 .

[106]  J. Barré,et al.  Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin , 1997, Antimicrobial agents and chemotherapy.

[107]  F. Tenover,et al.  Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. , 1992, The Pediatric infectious disease journal.

[108]  C. Berkey,et al.  Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. , 1997, JAMA.

[109]  D. Hansman.  Penicillin-insensitive pneumococci. , 1976, British medical journal.

[110]  D. Greenberg,et al.  Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. , 1996, The Pediatric infectious disease journal.

[111]  G. Kanra,et al.  Beneficial effects of dexamethasone in children with pneumococcal meningitis. , 1995, The Pediatric infectious disease journal.

[112]  I. Morrissey,et al.  The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae. , 1997, The Journal of antimicrobial chemotherapy.

[113]  A. Maroli,et al.  Efficacy and safety of grepafloxacin 600 mg daily for 10 days in patients with community-acquired pneumonia. , 1997, Clinical therapeutics.

[114]  J. Connor,et al.  Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. , 1991, The Pediatric infectious disease journal.

[115]  R. Dagan,et al.  Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group , 1995, Antimicrobial agents and chemotherapy.

[116]  J. Dorca,et al.  Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. , 1987, The New England journal of medicine.

[117]  G. Sambataro,et al.  Human pharmacokinetics and distribution in various tissues of ceftriaxone. , 1986, Chemotherapy.

[118]  E. Diaz,et al.  Appearance of resistance to beta-lactam antibiotics during therapy for Streptococcus pneumoniae meningitis. , 1995, The Journal of pediatrics.

[119]  S. Kaplan,et al.  Dexamethasone Therapy for Children With Bacterial Meningitis , 1995, Pediatrics.

[120]  F. Tenover,et al.  Invasive pneumococci with high level penicillin and cephalosporin resistance at a mid-south children's hospital. , 1994, The Pediatric infectious disease journal.

[121]  L. Taber,et al.  Prolonged pneumococcal meningitis due to an organism with increased resistance to penicillin. , 1976, Pediatrics.

[122]  D. Teele,et al.  Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Greater Boston Otitis Media Study Group. , 1997, Pediatrics.

[123]  M. Jacobs,et al.  Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci , 1996, Antimicrobial agents and chemotherapy.

[124]  F. Fraschini,et al.  Serum protein binding and extravascular diffusion of methoxyimino cephalosporins. Time courses of free and total concentrations of cefotaxime and ceftriaxone in serum and pleural exudate. , 1990, The Journal of antimicrobial chemotherapy.

[125]  C. John.  Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[126]  K. Singh,et al.  In vitro activity of the trinem sanfetrinem (GV104326) against gram-positive organisms , 1996, Antimicrobial agents and chemotherapy.

[127]  S. Buckingham,et al.  Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia. , 1998, The Journal of pediatrics.

[128]  J. Pocidalo,et al.  In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia , 1992, Antimicrobial Agents and Chemotherapy.

[129]  S. L. Orlicek,et al.  Septic arthritis and osteomyelitis caused by penicillin and cephalosporin-resistant Streptococcus pneumoniae in a children's hospital. , 1996, The Pediatric infectious disease journal.

[130]  V. Madrigal,et al.  Recurrent meningitis from a multiply resistant Streptococcus pneumoniae strain treated with erythromycin. , 1991, The Pediatric Infectious Disease Journal.

[131]  J. R. Parsons,et al.  Bacteremia With Streptococcus pneumoniae: Implications for Therapy and Prevention , 1996 .

[132]  E. Cantón,et al.  Risk/benefit in the treatment of children with imipenem-cilastatin for meningitis caused by penicillin-resistant pneumococcus. , 1993, Journal of chemotherapy.

[133]  A. Barry,et al.  In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents , 1996, Antimicrobial agents and chemotherapy.

[134]  Henry Nider,et al.  Report of the Committee on Infectious Diseases , 1989 .

[135]  M. Marks,et al.  Penicillin-insensitive pneumococci. Case report and review. , 1979, American journal of diseases of children.

[136]  Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. , 1988, The New England journal of medicine.

[137]  T. Similowski,et al.  Pyogenic bacterial pneumonia in human immunodeficiency virus-infected inpatients: a clinical, radiological, microbiological, and epidemiological study. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[138]  P. Appelbaum.  Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae. , 1996, The Pediatric infectious disease journal.

[139]  J. Bradley,et al.  Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis , 1995, Antimicrobial agents and chemotherapy.